Anders Bjartell, Board member: MD, PhD FEBU, Professor in Urology, Skåne university Hospital, Malmö. Assistant Dean Medical Faculty, Lund University. Appointed Professor in Clinical Urology and Senior Consultant at Skåne University Hospital in Malmö 2006. National principal investigator for several trials of new drugs in castration resistant prostate cancer and Head of the clinical trial unit at the Urology Department at the same hospital. He leads a research group in translational prostate cancer research with long term experience in prostate cancer biomarkers. His research also encompasses clinical projects on robotic surgery, imaging, and drug development. Participation in several EU-sponsored prostate cancer projects. Published nearly 200 peerreviewed articles.

Anders Bjartell, Board member: MD, PhD FEBU, Professor in Urology, Skåne university Hospital, Malmö. Assistant Dean Medical Faculty, Lund University. Appointed Professor in Clinical Urology and Senior Consultant at Skåne University Hospital in Malmö 2006. National principal investigator for several trials of new drugs in castration resistant prostate cancer and Head of the clinical trial unit at the Urology Department at the same hospital. He leads a research group in translational prostate cancer research with long term experience in prostate cancer biomarkers. His research also encompasses clinical projects on robotic surgery, imaging, and drug development. Participation in several EU-sponsored prostate cancer projects. Published nearly 200 peerreviewed articles.